Harry Drabkin: Clinical Trials

1 trial sponsored by Harry Drabkin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow Harry Drabkin: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sunitinib Before and After Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed By Surgery
sunitinib malate, gene expression analysis, reverse transcriptase-polymerase chain reaction - Kidney Cancer
Phase 1TerminatedHarry Drabkin172008-10-012015-10-22

Conditions studied

Carcinoma, Renal Cell (1)  ·  Kidney Neoplasms (1)

Interventions

Blotting, Western (1)  ·  Chemotherapy, Adjuvant (1)  ·  Gene Expression Profiling (1)  ·  Immunohistochemistry (1)  ·  Neoadjuvant Therapy (1)  ·  Reverse Transcriptase Polymerase Chain Reaction (1)  ·  Sunitinib (1)

Countries

United States (1)

Top investigators

Harry A. Drabkin, MD (1)